Skip to main content
Top
Published in: Clinical Drug Investigation 1/2000

01-05-2000 | Review Article

Assessment and Differential Diagnosis of Iron-Deficiency Anaemia during Pregnancy

Author: Dr Christian Breymann

Published in: Clinical Drug Investigation | Special Issue 1/2000

Login to get access

Abstract

Anaemia is one of the most common risk factors in the area of obstetrics and perinatal medicine. During pregnancy and in the puerperium it is associated with an increased incidence of both maternal and fetal morbidity and mortality, the extent of which is dependent upon the severity of anaemia and the resulting complications.
In order to correctly diagnose the type and degree of anaemia, a prerequisite for selection of the proper therapy, one must first of all correctly differentiate between ‘relative anaemia’, the physiological anaemia of pregnancy caused by the normal plasma volume increase during pregnancy, and ‘real anaemias’ with various different pathophysiological causes. When defining the haemoglobin cut-off value for anaemia in pregnancy, the extent of plasma volume changes with respect to gestational age must be taken into consideration. It has been found that haemoglobin values <110 g/L in the first and third trimesters, and <105 g/L in the second trimester, may point to an anaemic condition that should be further clarified. Among the most important differential diagnoses for anaemia during pregnancy are: (i) iron-deficiency anaemia and the preceding stages of iron depletion; (ii) haemoglobinopathies (thalassaemia, sickle cell anaemia); (iii) anaemia resulting from infections, e.g malaria; and (iv) renal anaemia, for example in pregnant women with renal insufficiency or a renal transplant.
Literature
1.
go back to reference Centers for Disease Control. Criteria for anemia in children and childbearing-aged women. MMWR Morb Mortal Wkly Rep 1989; 38(22): 400–4 Centers for Disease Control. Criteria for anemia in children and childbearing-aged women. MMWR Morb Mortal Wkly Rep 1989; 38(22): 400–4
2.
go back to reference Bridges K. Iron Imbalance during pregnancy. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 113–28 Bridges K. Iron Imbalance during pregnancy. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 113–28
3.
go back to reference Guidozzi F, Patel R, Mc Phail A. A prospective study of iron status in white and black pregnant women in an urban hospital. S Afr Med J 1995; 85(3): 171–3 Guidozzi F, Patel R, Mc Phail A. A prospective study of iron status in white and black pregnant women in an urban hospital. S Afr Med J 1995; 85(3): 171–3
4.
go back to reference Milman N, Agger A, Nielsen O. Iron status markers and serum erythropoietin in 120 mothers and newborn infants; effect of iron supplementation in normal pregnancy. Acta Obstet Gynecol Scand 1994; 73: 200–4PubMedCrossRef Milman N, Agger A, Nielsen O. Iron status markers and serum erythropoietin in 120 mothers and newborn infants; effect of iron supplementation in normal pregnancy. Acta Obstet Gynecol Scand 1994; 73: 200–4PubMedCrossRef
5.
go back to reference Hercberg S, Galan P, Preziosi P, et al. Consequences of iron deficiency in pregnant women: current issues. Clin Drug Invest 1999; 18Suppl. 1: 1–7 Hercberg S, Galan P, Preziosi P, et al. Consequences of iron deficiency in pregnant women: current issues. Clin Drug Invest 1999; 18Suppl. 1: 1–7
6.
go back to reference Hallberg L. Prevention of iron deficiency. Baillieres Clin Hematol 1994; 7(4): 805–14CrossRef Hallberg L. Prevention of iron deficiency. Baillieres Clin Hematol 1994; 7(4): 805–14CrossRef
7.
go back to reference Seefried B. Vergleichende Untersuchung von hämatologischen Parametern und des Eisenstoffwechsels von Müttern und Neugeborenen unter Anwendung der Retikulozyten-flowzytometrie [dissertation]. Klinik f. Geburtshilfe, Universität Zürich, 1995 Seefried B. Vergleichende Untersuchung von hämatologischen Parametern und des Eisenstoffwechsels von Müttern und Neugeborenen unter Anwendung der Retikulozyten-flowzytometrie [dissertation]. Klinik f. Geburtshilfe, Universität Zürich, 1995
8.
go back to reference Kaufer M, Casanueva E. Relation of prepregnancy serum ferritin levels to hemoglobin levels throughout pregnancy. Eur J Clin Nutr 1990; 44: 709–15PubMed Kaufer M, Casanueva E. Relation of prepregnancy serum ferritin levels to hemoglobin levels throughout pregnancy. Eur J Clin Nutr 1990; 44: 709–15PubMed
9.
go back to reference Cook J, Finch C, Smith N. Evaluation of the iron status of a population. Blood 1976; 48: 449–55PubMed Cook J, Finch C, Smith N. Evaluation of the iron status of a population. Blood 1976; 48: 449–55PubMed
10.
go back to reference Gibson R. Assessement of iron status. In: Gibson R, editor. Principles of nutritional assessement. New York: Oxford University Press, 1990: 349–76 Gibson R. Assessement of iron status. In: Gibson R, editor. Principles of nutritional assessement. New York: Oxford University Press, 1990: 349–76
11.
go back to reference Cook J, Finch C, Smith N: Evaluation of the iron status of a population. Blood 1976; 48: 449–55PubMed Cook J, Finch C, Smith N: Evaluation of the iron status of a population. Blood 1976; 48: 449–55PubMed
12.
go back to reference Goepel E, Ulmer H, Neth R. Premature labor contractions and the value of serum ferritin during pregnancy. Gynaecol Obstet Invest 1988; 26: 265–73CrossRef Goepel E, Ulmer H, Neth R. Premature labor contractions and the value of serum ferritin during pregnancy. Gynaecol Obstet Invest 1988; 26: 265–73CrossRef
13.
go back to reference Perewusnyk G, Guntermann H, Breymann C, et al. Bedeutung von Neopterin, Ferritin und sTfR bei der peripartalen Beurteilung des Eisenstatus. Gynäkol Geburtshilfliche Rundsch 1999; 39: 156 Perewusnyk G, Guntermann H, Breymann C, et al. Bedeutung von Neopterin, Ferritin und sTfR bei der peripartalen Beurteilung des Eisenstatus. Gynäkol Geburtshilfliche Rundsch 1999; 39: 156
14.
go back to reference Schaefer R, Schaefer L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. J Perinat Med 1995; 23: 83–8PubMedCrossRef Schaefer R, Schaefer L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. J Perinat Med 1995; 23: 83–8PubMedCrossRef
15.
go back to reference Breymann C, Perewusnyk G, Guntermann H, et al. Unrecognised iron deficiency in critical illness. Lancet 1999; 353(9155): 841–2PubMedCrossRef Breymann C, Perewusnyk G, Guntermann H, et al. Unrecognised iron deficiency in critical illness. Lancet 1999; 353(9155): 841–2PubMedCrossRef
16.
go back to reference Krafft A, Breymann C, Schneider J, et al. Neopterin und sTfR bei vermeintlicher “schwerer Eisenmangelanämie” in der Schwangerschaft. Gynäkol Geburtshilfliche Rundsch 1999; 39: 145 Krafft A, Breymann C, Schneider J, et al. Neopterin und sTfR bei vermeintlicher “schwerer Eisenmangelanämie” in der Schwangerschaft. Gynäkol Geburtshilfliche Rundsch 1999; 39: 145
17.
go back to reference Breymann C, Major A, Richter C, et al. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study. J Perinat Med 1995; 23: 89–98PubMedCrossRef Breymann C, Major A, Richter C, et al. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study. J Perinat Med 1995; 23: 89–98PubMedCrossRef
18.
go back to reference Beguin Y, Lipcsei G, Thoumsin H, et al. Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood 1991; 78: 89–91PubMed Beguin Y, Lipcsei G, Thoumsin H, et al. Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood 1991; 78: 89–91PubMed
19.
go back to reference Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89(3): 1052–7PubMed Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89(3): 1052–7PubMed
20.
go back to reference ACOG. Hemoglobinopathies in pregnancy. ACOG Tech Bull 1996 (220): 1-9 ACOG. Hemoglobinopathies in pregnancy. ACOG Tech Bull 1996 (220): 1-9
21.
go back to reference Charache S. Hemoglobinopathies. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 171–81 Charache S. Hemoglobinopathies. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 171–81
22.
go back to reference Breymann C, Fibach E, Visca E, et al. Induction of fetal haemoglobin synthesis with rhEPO in anemic patients with heterozygous beta-thalassaemia during pregnancy. J Matern Fet Med 1999; 8: 1–7CrossRef Breymann C, Fibach E, Visca E, et al. Induction of fetal haemoglobin synthesis with rhEPO in anemic patients with heterozygous beta-thalassaemia during pregnancy. J Matern Fet Med 1999; 8: 1–7CrossRef
32.
go back to reference McCalla C. Sickle cell disease in pregnancy. Postgrad Obstet Gynecol 1994; 14(3): 1–5 McCalla C. Sickle cell disease in pregnancy. Postgrad Obstet Gynecol 1994; 14(3): 1–5
24.
go back to reference Warth J. Sickle cell disease. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 183–97 Warth J. Sickle cell disease. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 183–97
25.
go back to reference Fuchs D, Zangerle R, Dworzak E, et al. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 1993; 50: 90–4PubMedCrossRef Fuchs D, Zangerle R, Dworzak E, et al. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 1993; 50: 90–4PubMedCrossRef
26.
go back to reference Spivak J. Serum immunoreactive erythropoietin in health and disease. J Perinat Med.1995; 23: 13–7PubMedCrossRef Spivak J. Serum immunoreactive erythropoietin in health and disease. J Perinat Med.1995; 23: 13–7PubMedCrossRef
27.
go back to reference Rosenlöf K, Kivivuori S, Riska C, et al. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrol 1995; 43(4): 249–55PubMed Rosenlöf K, Kivivuori S, Riska C, et al. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrol 1995; 43(4): 249–55PubMed
28.
go back to reference Braga J, Marques R, Branco A, et al. Maternal and perinatal implications of the use of human recombinant erythropoietin. Acta Obstet Gynecol Scand 1996; 75: 449–53PubMedCrossRef Braga J, Marques R, Branco A, et al. Maternal and perinatal implications of the use of human recombinant erythropoietin. Acta Obstet Gynecol Scand 1996; 75: 449–53PubMedCrossRef
Metadata
Title
Assessment and Differential Diagnosis of Iron-Deficiency Anaemia during Pregnancy
Author
Dr Christian Breymann
Publication date
01-05-2000
Publisher
Springer International Publishing
Published in
Clinical Drug Investigation / Issue Special Issue 1/2000
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI
https://doi.org/10.2165/00044011-200019001-00003